By Elise Haulund, Katherine Dillinger, Meg Tirrell, CNN (CNN) — The US Food and Drug Administration on Wednesday approved the United States' first mRNA-based flu vaccine for adults 50 and older, drugmaker Moderna said. "Flu remains a significant public health challenge, and mFLUSIVA provides an important new option for America's seniors," Moderna CEO Stephane Bancel
By Elise Haulund, Katherine Dillinger, Meg Tirrell, CNN (CNN) — The US Food and Drug Administration on Wednesday approved the United States' first mRNA-based flu vaccine for adults 50 and older, drugmaker...
"Flu remains a significant public health challenge, and mFLUSIVA provides an important new option for America's seniors," Moderna CEO Stephane Bancel
The page is ready to read now. The fuller skim-friendly version will appear here automatically.
By Elise Haulund, Katherine Dillinger, Meg Tirrell, CNN (CNN) — The US Food and Drug Administration on Wednesday approved the United States' first mRNA-based flu vaccine for adults 50 and older, drugmaker Moderna said. "Flu remains a significant public health challenge, and mFLUSIVA provides an important new option for America's seniors," Moderna CEO Stephane Bancel
Open the app view to save this story, compare related coverage, and continue from the same source.